BC Innovations | Aug 5, 2010
Distillery Therapeutics

Indication: Cardiovascular disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cardiovascular disease Heart failure Regulator of G-protein signaling 5 (RGS5); MAP kinase kinase 1 (MAP2K1; MEK1); MAP kinase 3 (MAPK3; ERK-1); MAPK1 (ERK-2) Mouse studies suggest...
BC Innovations | May 1, 2008
Targets & Mechanisms

Opening a Door into Solid Tumors

The irregular and leaky vasculature of tumors has been a major obstacle to the effective delivery of chemotherapeutics and immunotherapies to the cancerous tissues they target. 1 A paper in Nature now suggests that inhibiting...
BC Week In Review | Sep 7, 1999
Company News

Cadus Pharmaceutical Corp. other research news

KDUS researchers published in Nature Biotechnology yeast-based genetic screens that are designed to identify mammalian non-receptor proteins that modulate G-protein signaling. The screens involve yeast whose growth is conditional upon either activation or inactivation of...
Items per page:
1 - 3 of 3